← Back to home

The Immunobiological Technology Institute (bio-manguinhos) / Oswaldo Cruz Foundation (fiocruz)

Clinical trials sponsored by The Immunobiological Technology Institute (bio-manguinhos) / Oswaldo Cruz Foundation (fiocruz), explained in plain language.

Not yet recruiting 1

Brazil tests homegrown mRNA booster against COVID-19

⭐️ VACCINE ⭐️ Not yet recruiting

This early-stage trial tests a new mRNA COVID-19 booster vaccine made by Bio-Manguinhos/Fiocruz. About 90 healthy adults aged 18-59 will receive one of three doses (25, 50, or 100 micrograms) to check safety and immune response. The study is not yet recruiting and will monitor pa…

Phase: PHASE1 • Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 13:06 UTC

The Immunobiological Technology Institute (bio-manguinhos) / Oswaldo Cruz Foundation (fiocruz)

Brazil tests homegrown mRNA booster against COVID-19